These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17915329)

  • 1. Hypothesis: TCR signal transduction--A novel tri-modular signaling system.
    Amon MA; Manolios N
    Mol Immunol; 2008 Feb; 45(4):876-80. PubMed ID: 17915329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD3 gamma epsilon/delta epsilon signaling module provides normal T cell functions in the absence of the TCR zeta immunoreceptor tyrosine-based activation motifs.
    Pitcher LA; Mathis MA; Young JA; DeFord LM; Purtic B; Wulfing C; van Oers NS
    Eur J Immunol; 2005 Dec; 35(12):3643-54. PubMed ID: 16259006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of unique antibodies directed against each of the six different phosphotyrosine residues within the T cell receptor CD3ζ chain.
    Gelkop S; Weisman B; Pulak RN; Zharhary D; Isakov N
    J Immunol Methods; 2012 Jan; 375(1-2):129-37. PubMed ID: 22020291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deconstructing the form and function of the TCR/CD3 complex.
    Kuhns MS; Davis MM; Garcia KC
    Immunity; 2006 Feb; 24(2):133-9. PubMed ID: 16473826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A permissive geometry model for TCR-CD3 activation.
    Minguet S; Schamel WW
    Trends Biochem Sci; 2008 Feb; 33(2):51-7. PubMed ID: 18201888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-TCR/CD3 and TCR/CD3 complexes: decamers with differential signalling properties?
    Jacobs H
    Immunol Today; 1997 Dec; 18(12):565-9. PubMed ID: 9425732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure and function of lymphocyte TCR/CD3 complex].
    Boćko D; Frydecka I
    Postepy Hig Med Dosw; 2003; 57(5):519-29. PubMed ID: 14737968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of extracellular interactions impairs T cell receptor-CD3 complex stability and signaling.
    Kuhns MS; Davis MM
    Immunity; 2007 Mar; 26(3):357-69. PubMed ID: 17368054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD3 epsilon subunit of the TCR contains endocytosis signals.
    Borroto A; Lama J; Niedergang F; Dautry-Varsat A; Alarcón B; Alcover A
    J Immunol; 1999 Jul; 163(1):25-31. PubMed ID: 10384095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structurally altered D,L-amino acid TCRalpha transmembrane peptide interacts with the TCRalpha and inhibits T-cell activation in vitro and in an animal model.
    Quintana FJ; Gerber D; Bloch I; Cohen IR; Shai Y
    Biochemistry; 2007 Mar; 46(9):2317-25. PubMed ID: 17288453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell receptor signal transmission: who gives an ITAM?
    Pitcher LA; van Oers NS
    Trends Immunol; 2003 Oct; 24(10):554-60. PubMed ID: 14552840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defect in TCR-CD3zeta signaling mediates T cell hypo-responsiveness in mesenteric lymph node.
    Yi HJ; Lee CG; Kwon HK; So JS; Sahoo A; Hwang JS; Jash A; Hwang KC; Im SH
    Mol Immunol; 2008 Aug; 45(14):3748-55. PubMed ID: 18619676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The short length of the extracellular domain of zeta is crucial for T cell antigen receptor function.
    Minguet S; Swamy M; Schamel WW
    Immunol Lett; 2008 Mar; 116(2):195-202. PubMed ID: 18207249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition.
    Collier S; Bolte A; Manolios N
    Scand J Immunol; 2006 Oct; 64(4):388-91. PubMed ID: 16970679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of CD3gammaepsilon and CD3deltaepsilon dimer expression during murine T cell development.
    Laird RM; Hayes SM
    Mol Immunol; 2009 Dec; 47(2-3):582-9. PubMed ID: 19819020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization and intracellular fate of TCR-CD3 complexes.
    Alcover A; Alarcón B
    Crit Rev Immunol; 2000; 20(4):325-46. PubMed ID: 11100805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous T cell receptor signaling required for synapse maintenance and full effector potential.
    Huppa JB; Gleimer M; Sumen C; Davis MM
    Nat Immunol; 2003 Aug; 4(8):749-55. PubMed ID: 12858171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full activation of the T cell receptor requires both clustering and conformational changes at CD3.
    Minguet S; Swamy M; Alarcón B; Luescher IF; Schamel WW
    Immunity; 2007 Jan; 26(1):43-54. PubMed ID: 17188005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A chimeric T cell receptor with super-signaling properties.
    Petersen TR; Gülland S; Bettelli E; Kuchroo V; Palmer E; Bäckström BT
    Int Immunol; 2004 Jul; 16(7):889-94. PubMed ID: 15148288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different role for mouse and human CD3delta/epsilon heterodimer in preT cell receptor (preTCR) function: human CD3delta/epsilon heterodimer restores the defective preTCR function in CD3gamma- and CD3gammadelta-deficient mice.
    Pan Q; Brodeur JF; Drbal K; Dave VP
    Mol Immunol; 2006 Apr; 43(11):1741-50. PubMed ID: 16412509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.